Safety, efficacy, and dosage of 1% pimecrolimus cream for the treatment of atopic dermatitis in daily practice.

Jann Lübbe; Sheila F Friedlander; Bernard Cribier; Marie-Anne Morren; Amaro García-Díez; Carlo Gelmetti; Heidelore Hofmann; Ronald H Houwing; Stephen Kownacki; Richard G B Langley

doi:10.2165/00128071-200607020-00005

Safety, efficacy, and dosage of 1% pimecrolimus cream for the treatment of atopic dermatitis in daily practice.

Identifier:nobleid.org/w1/20260515/B3FAC276

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/B3FAC276.svg?ark=w1%2F20260515%2FB3FAC276)](https://nobleid.org/work/w1/20260515/B3FAC276)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Safety, efficacy, and dosage of 1% pimecrolimus cream for the treatment of atopic dermatitis in daily practice.

Identifier:nobleid.org/w1/20260515/B3FAC276

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/B3FAC276.svg?ark=w1%2F20260515%2FB3FAC276)](https://nobleid.org/work/w1/20260515/B3FAC276)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work